Reported Earlier, SAB Biotherapeutics Prices 19,324,677 Common Shares At $3.85 And 2,753,246 Pre-Funded Warrants At $3.8499 In $85M Public Offering
SAB Biotherapeutics Inc Ordinary Shares +0.26%
SAB Biotherapeutics Inc Ordinary Shares SABS | 3.86 | +0.26% |
Reported Earlier, SAB Biotherapeutics Prices 19,324,677 Common Shares At $3.85 And 2,753,246 Pre-Funded Warrants At $3.8499 In $85M Public Offering
